Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Jamie N. Bakkum-Gamez
With
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Females at least 18 years of age
Have an American Society of Anesthesiologists (ASA) Score of I to III
Are consented for primary, interval, or secondary cytoreduction for ovarian, tubal, or peritoneal cancer
Are scheduled to have their nasogastric tube removed before the first postoperative dose of study medication
Are able to understand the study procedures, have agreed to participate in the study program, and have voluntarily provided informed consent
You may not be if
Females younger than 18 years of age
Known non-gynecologic malignancy presenting with similar signs/symptoms as ovarian, tubal, or peritoneal cancer.
Have taken more than 7 consecutive days of therapeutic doses of opioids immediately prior to surgery
Use illicit drugs or abuse alcohol
Have had a prior total colectomy, gastrectomy, gastric bypass, or have a functional colostomy or ileostomy
Have an ongoing history of short bowel syndrome, chronic constipation (≤3 spontaneous bowel movements per week) or chronic diarrhea
Have received radiation therapy to the abdomen or pelvis within 3 months of scheduled surgery
Have chemotherapy or radiation induced bowel dysfunction
Are pregnant (identified by a positive urine or serum pregnancy test) or lactating, or are not postmenopausal (no menses for at least 1 year) and are of childbearing potential and not using an accepted method of birth control (ie, surgical sterilization, intrauterine contraceptive device, oral contraceptive, diaphragm, or condom in combination with contraceptive cream, jelly, or foam, or abstinence)
Have participated in another investigational drug or medical device study within 30 days of surgery or will be enrolled in another investigational drug or medical device study or any study in which active patient participation is required outside normal hospital data collection during the course of this study
Have clinically significant laboratory abnormalities at screening that would result in the cancellation of surgery
Have a diagnosis of severe hepatic insufficiency or end stage renal disease.
Have a history of previous surgeries, illness, or behavior that in the opinion of the investigator might confound the study results or pose additional risk in administering the study procedures
Are unable to understand the study procedures and are not able to voluntarily provided informed consent
Clareo Health | Accelerating Gastrointestinal Recovery
